StockDriftsStockDriftsTop 37 Frazier Life Sciences Management L P Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| MIRM | MIRUM PHARMACEUTICALS INC | 18.25% | 7.68M | $709.4M | +13.02%(+884.56K) | $30.66(+309.61%) | 2026-03-31 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 13.96% | 16.94M | $542.4M | +0.00%(+0) | $13.69(+154.41%) | 2026-03-31 | |
| ERAS | ERASCA INC | 10.27% | 24.68M | $399.2M | +8.56%(+1.95M) | $2.82(+554.15%) | 2026-03-31 | |
| BBIO | BRIDGEBIO PHARMA INC | 6.59% | 3.45M | $256.1M | -2.75%(-97.42K) | $21.17(+264.65%) | 2026-03-31 | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 5.99% | 9.87M | $232.6M | +0.00%(+0) | $19.28(+33.84%) | 2026-03-31 | |
| MBX | MBX BIOSCIENCES INC | 5.11% | 6.65M | $198.6M | +0.00%(+0) | $24.82(+132.83%) | 2026-03-31 | |
| PHAT | PHATHOM PHARMACEUTICALS INC | 3.56% | 12.47M | $138.5M | +0.00%(+0) | $12.77(-12.30%) | 2026-03-31 | |
| MAZE | MAZE THERAPEUTICS INC | 3.51% | 4.57M | $136.3M | +0.00%(+0) | $11.09(+181.87%) | 2026-03-31 | |
| KRYS | KRYSTAL BIOTECH INC | 3.2% | 481.3K | $124.3M | -1.46%(-7.15K) | $69.22(+441.87%) | 2026-03-31 | |
| TRVI | TREVI THERAPEUTICS INC | 3.05% | 9.94M | $118.6M | -3.12%(-319.86K) | $2.63(+582.29%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +36.97% | +156.99% |
| Top 20 Holdings Unweighted | +39.94% | +174.04% |
Sign up free to track Frazier Life Sciences Management L P, compare funds side by side, and get alerts the moment positions change.